Recall of all batches from the product: NOREPIRIN 2 mg/ml Injection
SFDA has issued a recall of all batch from the product: NOREPIRIN 2 mg/ml Injection Based on Decision No. 48/SFDA/1274/105 of the Committee for the Registration of Pharmaceutical Companies, Manufacturers, and Their Products, the manufacturer's registration has been suspended and all its products recalled due to critical observations concerning data integrity and aseptic processing..
For healthcare professionals: Stop dispensing the batch immediately. Embargo/Quarantine all remaining stock. Affected batch should be returned to the supplier.
For patients,
Consult your healthcare provider prior to discontinuing use of the affected batch, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.